Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia
- 186 Downloads
To perform a retrospective review of long-term outcome for patients with a first episode of acute urinary retention (AUR) who could void successfully after the initial trial without catheter (TWOC) after treatment with an alpha-adrenergic receptor blocker (AR blocker).
The records of 248 patients who presented with a first episode of AUR secondary to benign prostatic hyperplasia (BPH) and who could void successfully after the initial TWOC following treatment with an AR blocker were reviewed during the period January 1998 to December 2001. The characteristics of the patients and the subsequent outcomes were recorded. The primary outcome assessed was failed medical treatment within the five-year follow-up period. Factors correlated with the primary outcome were also assessed.
For these 248 patients, the median follow-up time was 33.0 months (range 0–96 months). The percentage of patients with failed medical treatment at 6, 12, 24, and 60 months was 11.6, 14.3, 28.4, and 50.5%, respectively. Multivariate analysis indicated that only a prostate size >50 ml and serum prostate specific antigen (PSA) level during AUR >10 ng/dl were significant predictors of subsequent requirement for surgical intervention after a successful TWOC.
Although AR blockers increased the success rate of TWOC, approximately half of the patients in this study still required additional intervention within five years. By using appropriate selection criteria, such as a large prostate size (>50 ml) or high serum PSA level during AUR (>10 μg/l), patients who are at greater risk of TWOC failure can be identified, and earlier surgical intervention can be offered to them.
KeywordsBenign prostate hyperplasia Acute urinary retention Alpha-adrenergic receptor blocker Trial without catheter
- 2.Chan PSF, Wong WS, Chan LW et al (1996) Can terazosin (alpha-blocker) relieve acute urinary retention and obviate the need for an indwelling urethral catheter? Br J Urol 77(Suppl 1):7Google Scholar
- 9.McConnell JD, Roehrborn CG, Bautista OM et al (2003) Medical therapy of prostatic symptoms (MTOPS) research group The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 349(25):2387–2398CrossRefPubMedGoogle Scholar
- 18.McConnell JD, Bruskewitz R, Walsh P et al (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride long-term efficacy and safety study group. N Engl J Med 338:557–563CrossRefPubMedGoogle Scholar
- 22.Patel AK, Chapple CR (2008) Medical management of lower urinary tract symptoms in men: current treatment and future approaches. Nat Clin Pract Urology 5(4):211–219Google Scholar